Verlag: American Foundation for the Blind Press
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 16,18
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 82,32
Anzahl: 1 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 98,85
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 1st edition. 252 pages. 10.00x0.28x7.00 inches. In Stock.
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Editor(s): Wolfe, Gil I.; Ciafalonia, Emma; Ruff, Robert; Meriggioli, Matthew N. Series: Annals of the New York Academy of Sciences. Num Pages: 252 pages. BIC Classification: MJE. Category: (P) Professional & Vocational. Dimension: 253 x 179 x 6. Weight in Grams: 320. . 2013. 1st Edition. Paperback. . . . . Books ship from the US and Ireland.
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Editor(s): Wolfe, Gil I.; Ciafalonia, Emma; Ruff, Robert; Meriggioli, Matthew N. Series: Annals of the New York Academy of Sciences. Num Pages: 252 pages, Illustrations. BIC Classification: MJE. Category: (P) Professional & Vocational. Dimension: 255 x 181 x 10. Weight in Grams: 346. . 2013. 1st Edition. Paperback. . . . . Books ship from the US and Ireland.
Anbieter: moluna, Greven, Deutschland
EUR 88,63
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality ra.